Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Clinical trial NCT07214779 · RECRUITING
Trial details
- NCT number
- NCT07214779
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-09
- Primary completion
- 2028-11-15
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.